Back to search
FDAFDA · Food and drugs·Recall number D-1092-2017

GEC LX Laxoplex 60 capsules Dietary Supplement, 60 count bottle, Manufactured by GEC, McKinney, TX, 75070, UPC: 700580499842

Published August 23, 2017 · Recall initiated: May 5, 2017

Summary

FDA records drug Class I recall D-1092-2017, published August 23, 2017 and initiated May 5, 2017. Recalling firm: Genetic Edge Compounds LLC; Status: Terminated; Reported quantity: 1759 bottles ( 105, 540 capsules); Lot: All lots. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: FDA analysis found the product to tainted with undeclared anabolic steroids and steroid like substances.

What to do

Voluntary: Firm initiated · Press Release

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Genetic Edge Compounds LLC
Distributor
Nationwide
UPC
700580499842
Lot
All lots.
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was GEC LX Laxoplex 60 capsules Dietary Supplement, 60 count bottle, Manufactured by GEC, McKinney, TX, 75070, UPC: 700580499842 recalled?

Yes. FDA published recall D-1092-2017 on August 23, 2017. Reported hazard: Marketed Without An Approved NDA/ANDA: Tainted Product Marketed As a Dietary Supplement: FDA analysis found the product to tainted with undeclared anabolic steroids and steroid like substances.

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. UPC: 700580499842.